109 related articles for article (PubMed ID: 21834748)
1. Crotamine toxicity and efficacy in mouse models of melanoma.
Pereira A; Kerkis A; Hayashi MA; Pereira AS; Silva FS; Oliveira EB; Prieto da Silva AR; Yamane T; Rádis-Baptista G; Kerkis I
Expert Opin Investig Drugs; 2011 Sep; 20(9):1189-200. PubMed ID: 21834748
[TBL] [Abstract][Full Text] [Related]
2. Oral treatment with a rattlesnake native polypeptide crotamine efficiently inhibits the tumor growth with no potential toxicity for the host animal and with suggestive positive effects on animal metabolic profile.
Campeiro JD; Marinovic MP; Carapeto FC; Dal Mas C; Monte GG; Carvalho Porta L; Nering MB; Oliveira EB; Hayashi MAF
Amino Acids; 2018 Feb; 50(2):267-278. PubMed ID: 29235017
[TBL] [Abstract][Full Text] [Related]
3. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
[TBL] [Abstract][Full Text] [Related]
4. The natural cell-penetrating peptide crotamine targets tumor tissue in vivo and triggers a lethal calcium-dependent pathway in cultured cells.
Nascimento FD; Sancey L; Pereira A; Rome C; Oliveira V; Oliveira EB; Nader HB; Yamane T; Kerkis I; Tersariol IL; Coll JL; Hayashi MA
Mol Pharm; 2012 Feb; 9(2):211-21. PubMed ID: 22142367
[TBL] [Abstract][Full Text] [Related]
5. The in-vitro and in-vivo inhibitory activity of biflorin in melanoma.
Vasconcellos MC; Bezerra DP; Fonseca AM; Araújo AJ; Pessoa C; Lemos TL; Costa-Lotufo LV; de Moraes MO; Montenegro RC
Melanoma Res; 2011 Apr; 21(2):106-14. PubMed ID: 21346641
[TBL] [Abstract][Full Text] [Related]
6. [Anti-invasive and anti-metastatic effect of ampelopsin on melanoma].
Zheng HQ; Liu DY
Ai Zheng; 2003 Apr; 22(4):363-7. PubMed ID: 12703989
[TBL] [Abstract][Full Text] [Related]
7. Antimetastatic, antineoplastic, and toxic effects of 4-hydroxycoumarin in a preclinical mouse melanoma model.
Salinas-Jazmín N; de la Fuente M; Jaimez R; Pérez-Tapia M; Pérez-Torres A; Velasco-Velázquez MA
Cancer Chemother Pharmacol; 2010 Apr; 65(5):931-40. PubMed ID: 19690859
[TBL] [Abstract][Full Text] [Related]
8. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L
J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599
[TBL] [Abstract][Full Text] [Related]
9. Alkylating benzamides with melanoma cytotoxicity: experimental chemotherapy in a mouse melanoma model.
Wolf M; Eskerski H; Bauder-Wüst U; Haberkorn U; Eisenhut M
Melanoma Res; 2006 Dec; 16(6):487-96. PubMed ID: 17119449
[TBL] [Abstract][Full Text] [Related]
10. Anticancer properties of Ganoderma lucidum methanol extracts in vitro and in vivo.
Harhaji Trajković LM; Mijatović SA; Maksimović-Ivanić DD; Stojanović ID; Momcilović MB; Tufegdzić SJ; Maksimović VM; Marjanović ZS; Stosić-Grujicić SD
Nutr Cancer; 2009; 61(5):696-707. PubMed ID: 19838944
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect of tripeptide compound tyroservaltide on invasion and metastasis of mouse melanoma cell line B16-F10].
Che XC; Lu R; Hu JX; Zheng MN; Zhang MF; Wang S; Yu CY; Yang XL; Xing DH; Yao Z
Ai Zheng; 2006 Mar; 25(3):275-80. PubMed ID: 16536978
[TBL] [Abstract][Full Text] [Related]
12. Gold(III) porphyrin 1a prolongs the survival of melanoma-bearing mice and inhibits angiogenesis.
Lum CT; Huo L; Sun RW; Li M; Kung HF; Che CM; Lin MC
Acta Oncol; 2011 Jun; 50(5):719-26. PubMed ID: 21110776
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of monomethoxy poly(ethylene glycol)-poly (ε-caprolactone) micelle-encapsulated doxorubicin against mouse melanoma.
Zheng L; Gou M; Zhou S; Yi T; Zhong Q; Li Z; He X; Chen X; Zhou L; Wei Y; Qian Z; Zhao X
Oncol Rep; 2011 Jun; 25(6):1557-64. PubMed ID: 21455590
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of B16 melanoma metastases with the ruthenium complex imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate and down-regulation of tumor cell invasion.
Gava B; Zorzet S; Spessotto P; Cocchietto M; Sava G
J Pharmacol Exp Ther; 2006 Apr; 317(1):284-91. PubMed ID: 16368900
[TBL] [Abstract][Full Text] [Related]
15. PTD4-apoptin protein and dacarbazine show a synergistic antitumor effect on B16-F1 melanoma in vitro and in vivo.
Jin JL; Gong J; Yin TJ; Lu YJ; Xia JJ; Xie YY; Di Y; He L; Guo JL; Sun J; Noteborn MH; Qu S
Eur J Pharmacol; 2011 Mar; 654(1):17-25. PubMed ID: 21184754
[TBL] [Abstract][Full Text] [Related]
16. Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins.
Sun BS; Wang JH; Liu LL; Gong SL; Redmond HP
J Surg Oncol; 2007 Sep; 96(3):241-8. PubMed ID: 17469118
[TBL] [Abstract][Full Text] [Related]
17. The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution.
Rouleau C; Menon K; Boutin P; Guyre C; Yoshida H; Kataoka S; Perricone M; Shankara S; Frankel AE; Duesbery NS; Vande Woude G; Biemann HP; Teicher BA
Int J Oncol; 2008 Apr; 32(4):739-48. PubMed ID: 18360701
[TBL] [Abstract][Full Text] [Related]
18. Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma.
Nakajima M; Hayashi K; Egi Y; Katayama K; Amano Y; Uehata M; Ohtsuki M; Fujii A; Oshita K; Kataoka H; Chiba K; Goto N; Kondo T
Cancer Chemother Pharmacol; 2003 Oct; 52(4):319-24. PubMed ID: 12783205
[TBL] [Abstract][Full Text] [Related]
19. Crotamine Cell-Penetrating Nanocarriers: Cancer-Targeting and Potential Biotechnological and/or Medical Applications.
Hayashi MAF; Campeiro JD; Porta LC; Szychowski B; Alves WA; Oliveira EB; Kerkis I; Daniel MC; Karpel RL
Methods Mol Biol; 2020; 2118():61-89. PubMed ID: 32152971
[TBL] [Abstract][Full Text] [Related]
20. Liposomal N,N,N-trimethylsphingosine (TMS) as an inhibitor of B16 melanoma cell growth and metastasis with reduced toxicity and enhanced drug efficacy compared to free TMS: cell membrane signaling as a target in cancer therapy III.
Park YS; Hakomori S; Kawa S; Ruan F; Igarashi Y
Cancer Res; 1994 Apr; 54(8):2213-7. PubMed ID: 8174128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
